MTOR and metabolic syndrome: Adenosine monophosphate-activated protein kinase (AMPK) and mammalian targets of rapamycin (mTOR), as cellular nutrient and energy sensors, have been closely associated with metabolic syndrome-related diseases and might be effective targets for MetS prevention and therapy [4].